Janice Chen is the founder of Mammoth Biosciences. Mammoth Biosciences has raised $195M in total funding. Latest round: Series D.
Janice Chen is the co-founder and chief technology officer (CTO) of Mammoth Biosciences, a CRISPR-based diagnostics and therapeutics company founded in 2018. She focuses on advancing novel CRISPR systems to decode and manipulate genetic information for clinical and diagnostic applications.
Full founder directory · Investor directory · Company funding database · Fundraising library